Drug Shortage Report for ZAVESCA
Report ID | 225362 |
Drug Identification Number | 02250519 |
Brand name | ZAVESCA |
Common or Proper name | ZAVESCA |
Company Name | JANSSEN INC |
Market Status | MARKETED |
Active Ingredient(s) | MIGLUSTAT |
Strength(s) | 100MG |
Dosage form(s) | CAPSULE |
Route of administration | ORAL ORAL |
Packaging size | 90 |
ATC code | A16AX |
ATC description | OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | 2024-04-17 |
Actual start date | 2024-04-17 |
Estimated end date | 2024-05-01 |
Actual end date | 2024-05-01 |
Shortage status | Resolved |
Updated date | 2024-05-02 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 19 GREEN BELT DRIVE TORONTO, ONTARIO CANADA M3C 1L9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2024-05-02 | English | Compare |
v5 | 2024-05-01 | French | Compare |
v4 | 2024-05-01 | English | Compare |
v3 | 2024-04-18 | English | Compare |
v2 | 2024-04-17 | French | Compare |
v1 | 2024-04-17 | English | Compare |
Showing 1 to 6 of 6